MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung
Schildhaus et al. Clinical Cancer Research. $ARQL
ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
Regina et al. Molecular Cancer Therapeutics. (Angiochem)
High HER2 Expression Correlates with Response to the Combination of Lapatinib and Trastuzumab
Scaltriti et al. Clinical Cancer Research.
Meta-analysis for the Association between Overall Survival and Progression-Free Survival in Gastrointestinal Stromal Tumor
Ozer-Stillman et al. Clinical Cancer Research.
Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology
Brandon et al. Clinical Cancer Research.
Lots of TGFb kinase inhibitors in the literature over the years, but no one knew quite what to do with them. Immuno-onc redeems everything!
— Michael Gilman (@michael_gilman) February 23, 2015
Suppressing TGFβ Signaling in Regenerating Epithelia in an Inflammatory Microenvironment Is Sufficient to Cause Invasive Intestinal Cancer
Oshima et al. Cancer Research.
First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma
Rodon et al. Clinical Cancer Research. $LLY